IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $407,000 | -74.1% | 11,000 | -74.0% | 0.05% | +11.6% |
| Q1 2022 | $1,569,000 | +34.0% | 42,380 | +10.1% | 0.04% | +87.0% |
| Q4 2021 | $1,171,000 | -19.5% | 38,500 | -11.3% | 0.02% | -47.7% |
| Q3 2021 | $1,455,000 | -79.7% | 43,400 | -75.9% | 0.04% | -82.7% |
| Q2 2021 | $7,181,000 | +47.8% | 180,000 | +66.5% | 0.26% | +110.7% |
| Q1 2021 | $4,860,000 | +4.2% | 108,100 | +31.0% | 0.12% | +37.5% |
| Q4 2020 | $4,665,000 | +27.6% | 82,500 | +7.1% | 0.09% | -35.3% |
| Q3 2020 | $3,655,000 | +48.6% | 77,000 | +58.8% | 0.14% | -76.0% |
| Q3 2017 | $2,459,000 | – | 48,500 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |